Sezary disease is a type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. It primarily affects the lymph nodes of the head, face, and neck, leading to significant morbidity. Accurate coding with ICD-10 Code C84.11 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this rare condition.
ICD-10 Code C84.11 specifically denotes Sezary disease affecting the lymph nodes of the head, face, and neck. This condition is a leukemic form of cutaneous T-cell lymphoma, where malignant T-cells proliferate in the skin and lymphatic system. This code should be used in clinical documentation and billing when diagnosing patients with this specific manifestation of Sezary disease.
Sezary disease is a severe form of cutaneous T-cell lymphoma that can lead to systemic complications. It is characterized by the infiltration of malignant T-cells in the skin and lymph nodes, particularly affecting the head, face, and neck. Prompt recognition and treatment are crucial to prevent disease progression.
ICD-10 Code C84.11 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Sezary disease. This code aids in capturing the severity and extent of the disease, facilitating appropriate management in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.11 connects subjective patient-reported symptoms with objective clinical findings, leading to a formal diagnosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Sezary disease requires urgent medical intervention due to its aggressive nature. Treatment typically involves systemic therapies tailored to the patient's condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.11 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C84.11 for Sezary disease, lymph nodes of head, face, and neck
What are the common symptoms of Sezary disease?
Common symptoms include widespread erythroderma, severe itching, swollen lymph nodes, and the presence of atypical T-cells in the blood. Patients may also experience fatigue and weight loss.
How is Sezary disease diagnosed?
Diagnosis is typically made through clinical evaluation, skin biopsy, and laboratory tests that identify atypical T-cells in the bloodstream. Imaging studies may also be used to assess lymph node involvement.
What treatments are available for Sezary disease?
Treatment options include systemic therapies such as chemotherapy, biologics, and phototherapy. Supportive care for skin symptoms is also essential to manage the condition effectively.
Is Sezary disease contagious?
No, Sezary disease is not contagious. It is a malignancy of T-cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes